Evaluating superdisintegrants for their performance in orally disintegrating tablets containing lysozyme enzyme

Ildiko Olah, Jason Lasher, Geza Regdon, K. Pintye-Hódi, Gabriella Baki, Tamas Sovany

Research output: Contribution to journalArticle

Abstract

Orally disintegrating tablets (ODTs) are gaining importance and popularity due to their numerous advantages. Lysozyme, an enzyme with antibacterial properties, is currently only available as a conventional tablet and syrup. The main aims of this study were to formulate ODTs containing lysozyme using a variety of excipients and evaluate how formulation technology and excipient selection affected enzyme activity. Three different superdisintegrants in two concentrations, two different types of fillers, and three types of modern, ready-to-use co-processed excipients were investigated. The effect of the quality of the materials and the applied compression force were also studied. The investigated Critical Quality Attributes were disintegration time, dissolution profile and activity of lysozyme enzyme. A higher enzyme activity was found for ODTs with a higher hardness and density, containing the stabilizing agent in a smaller particle size. The structure of the superdisintegrant crystals had a greater impact on the disintegration time and dissolution profile of ODTs than the amount of superdisintegrants used. The results also revealed that despite the general advantages and effectiveness of ready-to-use excipients, the use of tailored formulations is more advantageous for sensitive drugs like enzymes.

Original languageEnglish
Pages (from-to)396-404
Number of pages9
JournalJournal of Drug Delivery Science and Technology
Volume49
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Excipients
Muramidase
Tablets
Enzymes
Hardness
Particle Size
Technology
Pharmaceutical Preparations

Keywords

  • Dissolution
  • Enzyme activity
  • Excipients
  • Lysozyme
  • Microscopy
  • Oral drug delivery
  • Solid dosage form

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Evaluating superdisintegrants for their performance in orally disintegrating tablets containing lysozyme enzyme. / Olah, Ildiko; Lasher, Jason; Regdon, Geza; Pintye-Hódi, K.; Baki, Gabriella; Sovany, Tamas.

In: Journal of Drug Delivery Science and Technology, Vol. 49, 01.02.2019, p. 396-404.

Research output: Contribution to journalArticle

@article{f068b6e4b65743cc87511d7493e8a9a3,
title = "Evaluating superdisintegrants for their performance in orally disintegrating tablets containing lysozyme enzyme",
abstract = "Orally disintegrating tablets (ODTs) are gaining importance and popularity due to their numerous advantages. Lysozyme, an enzyme with antibacterial properties, is currently only available as a conventional tablet and syrup. The main aims of this study were to formulate ODTs containing lysozyme using a variety of excipients and evaluate how formulation technology and excipient selection affected enzyme activity. Three different superdisintegrants in two concentrations, two different types of fillers, and three types of modern, ready-to-use co-processed excipients were investigated. The effect of the quality of the materials and the applied compression force were also studied. The investigated Critical Quality Attributes were disintegration time, dissolution profile and activity of lysozyme enzyme. A higher enzyme activity was found for ODTs with a higher hardness and density, containing the stabilizing agent in a smaller particle size. The structure of the superdisintegrant crystals had a greater impact on the disintegration time and dissolution profile of ODTs than the amount of superdisintegrants used. The results also revealed that despite the general advantages and effectiveness of ready-to-use excipients, the use of tailored formulations is more advantageous for sensitive drugs like enzymes.",
keywords = "Dissolution, Enzyme activity, Excipients, Lysozyme, Microscopy, Oral drug delivery, Solid dosage form",
author = "Ildiko Olah and Jason Lasher and Geza Regdon and K. Pintye-H{\'o}di and Gabriella Baki and Tamas Sovany",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.jddst.2018.12.012",
language = "English",
volume = "49",
pages = "396--404",
journal = "S.T.P. Pharma Sciences",
issn = "1773-2247",
publisher = "Editions de Sante",

}

TY - JOUR

T1 - Evaluating superdisintegrants for their performance in orally disintegrating tablets containing lysozyme enzyme

AU - Olah, Ildiko

AU - Lasher, Jason

AU - Regdon, Geza

AU - Pintye-Hódi, K.

AU - Baki, Gabriella

AU - Sovany, Tamas

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Orally disintegrating tablets (ODTs) are gaining importance and popularity due to their numerous advantages. Lysozyme, an enzyme with antibacterial properties, is currently only available as a conventional tablet and syrup. The main aims of this study were to formulate ODTs containing lysozyme using a variety of excipients and evaluate how formulation technology and excipient selection affected enzyme activity. Three different superdisintegrants in two concentrations, two different types of fillers, and three types of modern, ready-to-use co-processed excipients were investigated. The effect of the quality of the materials and the applied compression force were also studied. The investigated Critical Quality Attributes were disintegration time, dissolution profile and activity of lysozyme enzyme. A higher enzyme activity was found for ODTs with a higher hardness and density, containing the stabilizing agent in a smaller particle size. The structure of the superdisintegrant crystals had a greater impact on the disintegration time and dissolution profile of ODTs than the amount of superdisintegrants used. The results also revealed that despite the general advantages and effectiveness of ready-to-use excipients, the use of tailored formulations is more advantageous for sensitive drugs like enzymes.

AB - Orally disintegrating tablets (ODTs) are gaining importance and popularity due to their numerous advantages. Lysozyme, an enzyme with antibacterial properties, is currently only available as a conventional tablet and syrup. The main aims of this study were to formulate ODTs containing lysozyme using a variety of excipients and evaluate how formulation technology and excipient selection affected enzyme activity. Three different superdisintegrants in two concentrations, two different types of fillers, and three types of modern, ready-to-use co-processed excipients were investigated. The effect of the quality of the materials and the applied compression force were also studied. The investigated Critical Quality Attributes were disintegration time, dissolution profile and activity of lysozyme enzyme. A higher enzyme activity was found for ODTs with a higher hardness and density, containing the stabilizing agent in a smaller particle size. The structure of the superdisintegrant crystals had a greater impact on the disintegration time and dissolution profile of ODTs than the amount of superdisintegrants used. The results also revealed that despite the general advantages and effectiveness of ready-to-use excipients, the use of tailored formulations is more advantageous for sensitive drugs like enzymes.

KW - Dissolution

KW - Enzyme activity

KW - Excipients

KW - Lysozyme

KW - Microscopy

KW - Oral drug delivery

KW - Solid dosage form

UR - http://www.scopus.com/inward/record.url?scp=85058426586&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058426586&partnerID=8YFLogxK

U2 - 10.1016/j.jddst.2018.12.012

DO - 10.1016/j.jddst.2018.12.012

M3 - Article

AN - SCOPUS:85058426586

VL - 49

SP - 396

EP - 404

JO - S.T.P. Pharma Sciences

JF - S.T.P. Pharma Sciences

SN - 1773-2247

ER -